Role of Functional Neuroimaging with 123I-MIBG and 123I-FP-CIT in De Novo Parkinson’s Disease: A Multicenter Study
Background: Parkinson’s disease is a progressive neurodegenerative disorder, with incidence and prevalence rates of 8–18 per 100,000 people per year and 0.3–1%, respectively. As parkinsonian symptoms do not appear until approximately 50–60% of the nigral DA-releasing neurons have been lost, the impa...
Main Authors: | Maria Silvia De Feo, Viviana Frantellizzi, Nicoletta Locuratolo, Arianna Di Rocco, Alessio Farcomeni, Caterina Pauletti, Andrea Marongiu, Julia Lazri, Susanna Nuvoli, Francesco Fattapposta, Giuseppe De Vincentis, Angela Spanu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/13/8/1786 |
Similar Items
-
Computer-aided diagnosis for (123I)FP-CIT imaging: impact on clinical reporting
by: Jonathan Christopher Taylor, et al.
Published: (2018-05-01) -
A proposal of visual assessment of serotonergic deficits in parkinsonian syndromes: An 123I-FP-CIT SPECT study
by: Tomoko Totsune, et al.
Published: (2025-03-01) -
Utility of 123I-MIBG Standardized Uptake Value in Patients with Refractory Pheochromocytoma and Paraganglioma
by: Hiroshi Wakabayashi, et al.
Published: (2019-06-01) -
Semi-quantitative analysis of visually normal 123I-FP-CIT across three large databases revealed no difference between control and patients
by: Anthime Flaus, et al.
Published: (2023-04-01) -
Relevance of 123I-FP-CIT SPECT prescriptions for the diagnosis of parkinsonian syndromes
by: Marion Houot, et al.
Published: (2024-10-01)